XML 25 R9.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Cash flows from operating activities:      
Net loss $ (1,028,857) $ (204,149) $ (623,506)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:      
Depreciation 119,701 114,448 100,108
Equity Securities, FV-NI, Gain (Loss) (2,713) 4,098 (21,774)
Deferred tax benefit (10,119) (955) (11,901)
Share-Based Payment Arrangement, Noncash Expense 214,885 231,312 206,823
Gain on settlement of convertible notes (10,254) (10,324) 0
Amortization of Intangible Assets 95,158 92,160 97,450
Loss on sale of asset 0 0 13,244
Impairment of long-lived and indefinite-lived assets 869,460 621 15,969
Gain (Loss) On Contingent Consideration From Disposition Of Asset (9,200) (73,300) 0
Remeasurement of contingent consideration liabilities (3,346) (18,044) (56,617)
Non-cash lease expense 26,926 27,891 28,639
Other Noncash Income (Expense) (519) 899 10,835
Changes in assets and liabilities, net of effects of acquisition:      
Accounts receivable, net (46,259) (43,416) 61,088
Inventory, net (34,911) (7,690) (13,231)
Operating lease liabilities (25,783) (26,701) (20,646)
Accounts payable and accrued liabilities 43,538 82,750 (52,180)
Increase (Decrease) in Other Operating Assets (2,323) (11,618) (84)
Increase (Decrease) in Other Operating Liabilities 9,726 6,333 (1,324)
Net cash provided by (used in) operating activities 210,536 156,119 (223,559)
Cash flows from investing activities:      
Purchases of marketable securities (465,031) (139,854) (131,486)
Maturities and sales of marketable securities 205,821 363,156 453,072
Purchases of property, plant and equipment (135,989) (124,190) (214,462)
Proceeds from Sale of Productive Assets 0 0 25,000
Proceeds From Sale Of Investments In Privately-Held Companies 0 19,794 0
Payments to Acquire Other Investments (1,731) (16,564) (42,823)
Business combination, net of cash acquired and issuance costs 0 (52,413) (14,686)
Asset acquisitions, net of cash acquired (45,000) (500) 0
Other investing activities (225) 250 (549)
Net cash provided by (used in) investing activities (442,155) 49,679 74,066
Cash flows from financing activities:      
Proceeds from Accounts Receivable Securitization 0 0 50,000
Proceeds from exercise of common stock options 1,651 3,197 6,524
Proceeds in connection with the Company's employee stock purchase plan 31,227 28,344 25,491
Proceeds from issuance of convertible notes 266,750 137,976 0
Repayments of Accounts Receivable Securitization 50,000 0 0
Other financing activities (17,754) (9,751) (5,530)
Net cash provided by financing activities 231,874 159,766 76,485
Effects of exchange rate changes on cash and cash equivalents (3,294) 1,321 30
Net increase (decrease) in cash, cash equivalents, and restricted cash (3,039) 366,885 (72,978)
Cash, cash equivalents, and restricted cash at the beginning of period 609,675 242,790 315,768
Cash, cash equivalents, and restricted cash at the end of period 606,636 609,675 242,790
Non-cash investing and financing activities:      
Property, plant and equipment acquired but not paid 13,721 18,505 15,943
Stock Issued During Period, Value, Employee Benefit Plan 40,550 35,100 29,202
Supplemental disclosure of cash flow information:      
Interest paid 27,839 18,776 11,519
Reconciliation of cash, cash equivalents, and restricted cash:      
Cash and cash equivalents 600,889 605,378 242,493
Restricted cash — included in other long-term assets, net as of December 31, 2024 and 2023, and prepaid expenses and other current assets as of December 31, 2022 5,747 4,297 297
Total cash, cash equivalents, and restricted cash $ 606,636 $ 609,675 $ 242,790